Press Releases

Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III
read more Another Clinical Asset Using ProBioGen's GlymaxX® Technology Begins Phase III

ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production
read more ProBioGen’s Vaccine Production Cell Line AGE1.CR.pIX® Used for Clinical Production

ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology
read more ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck® Transposase Technology

ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit
read more ProBioGen Co-Develops New Freedom™ ExpiCHO-S™ Cell Line Development Kit

ProBioGen Celebrates "A New Dawn in Biotechnology"
read more ProBioGen Celebrates "A New Dawn in Biotechnology"

ProBioGen Receives Employer of the Future and Top Service Awards
read more ProBioGen Receives Employer of the Future and Top Service Awards

ProBioGen and City of Hope Announce Commercial License Agreement to Use AGE1.CR.pIX® Vaccine Manufacturing Platform for Cytomegalovirus (CMV) Vaccine
